EVLV.NASDAQEvolv Technologies Holdings, INC

8-K: Evolv Technologies Settles Stockholder Derivative Lawsuits

Sentiment:

Current Report (Form 8-K) Settlement of Litigation 10 August 2026 8:00 AM

📋All filings for Evolv Technologies Holdings, INC

Evolv Technologies Holdings, Inc. announced the preliminary approval of a settlement for stockholder derivative claims, resolving multiple lawsuits without requiring payment from the company.

Summary

Evolv Technologies Holdings, Inc. has reached a preliminary settlement for stockholder derivative claims that were filed or threatened on behalf of the company.
The settlement resolves consolidated actions in the U.S. District Court for Massachusetts and actions in the Delaware Court of Chancery, as well as a pre-suit litigation demand.
As part of the settlement, Evolv will implement specific corporate governance enhancements.
The company will not be required to make any payment to settle these claims; attorneys' fees and expenses for the plaintiffs' counsel, totaling $1,275,000, will be paid by the company's insurers.
The settlement requires court approval, with a hearing scheduled for October 21, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it resolves significant litigation without financial cost to the company, though it does involve corporate governance changes.

Positives

Resolves multiple stockholder derivative lawsuits, including consolidated actions and a pre-suit demand, without any payment from the company.
Attorneys' fees and expenses for plaintiffs' counsel, capped at $1,275,000, will be covered by the company's insurers.
The settlement includes the implementation of corporate governance enhancements, which are expected to benefit the company and its stockholders.
The company acknowledges that the litigation was a material factor in adopting these enhancements.

Negatives

The company's past marketing claims and accounting for certain sales transactions were under scrutiny, leading to investigations by the FTC and SEC.
The company had to restate that certain financial statements between Q2 2022 and Q2 2024 should not be relied upon due to inaccurate revenue recognition.
The company settled with the FTC on November 26, 2024, agreeing to refrain from certain marketing claims without adequate substantiation and offering contract cancellation options to eligible school customers.

Risks

The derivative matters arose from allegations of improper sales and revenue practices, failure to implement adequate internal controls, and misleading statements regarding the company's core product and technology.
The company's past marketing claims regarding Evolv Express's superiority to traditional metal detectors were questioned, leading to regulatory scrutiny.
The company previously disclosed that certain financial statements from Q2 2022 to Q2 2024 should not be relied upon due to accounting inaccuracies.

Future Outlook

The settlement is subject to final court approval. Upon approval, the company will implement specific corporate governance reforms for a period of at least five years. The company's financial statements from Q2 2022 to Q2 2024 were previously identified as unreliable due to accounting errors.

Management Comments

The Company acknowledges and has determined that the Reforms confer substantial corporate benefits upon Evolv and its stockholders and that the Settlement is in all respects fair and reasonable and in the best interests of the Company and its stockholders.
The Company further acknowledges and agrees that the initiation and prosecution of the Derivative Matters were the cause of Evolv adopting and implementing the Reforms.

Industry Context

StockSavvy.ai notes that this settlement addresses issues related to marketing claims and financial reporting accuracy, which are critical areas of focus for technology companies, especially those in the security screening sector where efficacy and reliability are paramount. The implemented governance reforms aim to strengthen oversight in these areas.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Audit Committee Charter Amendments	Amendments include requiring periodic private sessions with management, internal auditor, and independent auditor; soliciting input from business unit representatives on public disclosures; and authorizing retention of independent consultants to strengthen internal controls.	Within 30 days of Settlement Effective Date	Enhances oversight and internal control review processes.
Marketing Policy Amendment	Ensures timely corrective disclosures and establishes a process for reporting concerns regarding policy violations.	Within 30 days of Settlement Effective Date	Aims to improve accuracy and transparency in marketing communications.
Disclosure Committee Charter Amendment	Adds a sales representative to the committee, provides examples of escalation triggers, and requires coordination with senior officers for accurate disclosures.	Within 30 days of Settlement Effective Date	Strengthens the committee's role in ensuring accurate and timely public disclosures.
Corporate Governance Guidelines Amendment	Amendments regarding the duties and responsibilities of the Lead Independent Director.	Within 30 days of Settlement Effective Date	Clarifies leadership roles and responsibilities at the board level.
General Counsel Role Enhancement	The General Counsel position will be specifically tasked with duties to assist the Board with oversight of legal and compliance matters, including updating the Code of Business Conduct and Ethics, evaluating internal controls, and managing complaints.	Within 30 days of Settlement Effective Date	Elevates the role of General Counsel in corporate compliance and legal oversight.
Annual Board Discussion Requirement	The Board will discuss annually Evolv's compliance with best revenue recognition practices, its Marketing Policy, and compliance with the FTC settlement's permanent injunction.	Within 30 days of Settlement Effective Date	Ensures regular board-level attention to critical financial and regulatory matters.
Enhanced Marketing Practices Oversight	Includes annual meetings between General Counsel and marketing leadership to discuss practices and claims, and monitoring of compliance training for sales and marketing employees.	Within 30 days of Settlement Effective Date	Improves oversight and compliance related to marketing activities.
Creation of Management-Level Compliance Committee	A new committee will be established to enhance compliance with laws, the Code of Business Conduct and Ethics, and internal policies, reporting to the Audit Committee.	Within 3 months of Settlement Effective Date	Establishes a dedicated management-level body for compliance oversight.

Legal Proceedings

Consolidated stockholder derivative action pending in the U.S. District Court for the District of Massachusetts, captioned In re Evolv Technologies Holdings, Inc. Stockholder Derivative Litigation, Master File No. 1:24-cv-12822-ADB.
Stockholder derivative actions pending in the Delaware Court of Chancery, captioned Bersch v. George, et al., C.A. No. 2025-0266-MTZ and Patrick v. Charlton, et al., C.A. No. 2025-1121-MTZ.
A pre-suit litigation demand asserted by Evolv stockholder Nicholas R. Ingrao.
Previous settlement with the FTC on November 26, 2024, resulting in a court-approved order on December 6, 2024.

Stakeholder Impact

Shareholders: The settlement resolves litigation that could have impacted the company's reputation and financial stability. The implemented governance reforms are intended to benefit shareholders by improving oversight and accountability.
Company: The company avoids financial outlay for the settlement and can focus on operations, though it must implement governance changes.
Management and Directors: The settlement releases current and former directors and officers from claims related to the derivative matters, providing resolution to past allegations.

Next Steps

A Settlement Hearing will be held on October 21, 2026, to determine final approval of the settlement.
Evolv will implement corporate governance reforms within 30 days following the Effective Date of the Settlement, which will remain in effect for at least five years.
The company will file this Current Report on Form 8-K with the SEC, including the Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions and the Stipulation and Agreement of Settlement.

Key Dates

Date	Description
August 5, 2026	Date of the Stipulation and Agreement of Settlement.
August 6, 2026	Date of the preliminary approval of the settlement by the U.S. District Court for the District of Massachusetts and the date of the filing of the Form 8-K.
October 21, 2026	Scheduled date for the Settlement Hearing to determine final approval of the settlement.
September 30, 2026	Deadline for stockholders to deliver written objections to the Court and counsel.

Recommendation

hold

The filing resolves significant litigation without financial cost to the company, which is positive. However, the underlying issues related to past marketing and accounting practices, and the need for substantial governance reforms, suggest a cautious approach. The company's future performance will depend on the effective implementation of these reforms and its ability to regain market confidence.

Keywords

derivative litigation, settlement, corporate governance, stockholder claims, litigation, SEC filing, FTC, revenue recognition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.